Northern Trust Corp Talis Biomedical Corp Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $77,679 - $138,097	-95,901 Reduced 77.49%	27,860 $22,000
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $5,027 - $16,202	-3,867 Reduced 3.03%	123,761 $175,000
Q4 2021 Feb 08, 2022	SELL	$3.81 - $6.17 $11,388 - $18,442	-2,989 Reduced 2.29%	127,628 $511,000
Q3 2021 Nov 15, 2021	SELL	$6.02 - $12.46 $49,333 - $102,109	-8,195 Reduced 5.9%	130,617 $817,000
Q2 2021 Aug 13, 2021	BUY	$9.62 - $14.56 $3,184 - $4,819	331 Added 0.24%	138,812 $1.53 Million
Q1 2021 May 12, 2021	BUY	$11.2 - $27.8 $1.55 Million - $3.85 Million	138,481 New	138,481 $1.78 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.